Surgical Treatment of Pancreatic Cancer

Journal of the American College of Surgeons

Volumn 205, Issue 4 SUPPL., 2007, Pages

  Büchler, Markus W ^a   Kleeff, Jörg ^a   Friess, Helmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANASTOMOSIS; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MALE; MORBIDITY; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANASTOMOSIS, SURGICAL; COMBINED MODALITY THERAPY; DRAINAGE; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; VASCULAR SURGICAL PROCEDURES;

EID: 34748902794     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.06.332     Document Type: Article

References (78)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
3. Kleeff J., Michalski C., Friess H., and Büchler M.W. Pancreatic cancer: From bench to five-year survival. Pancreas 33 (2006) 111-118
4. Neoptolemos J.P., Stocken D.D., Friess H., et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350 (2004) 1200-1210
5. Picozzi V.J., Kozarek R.A., and Traverso L.W. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185 (2003) 476-480
6. Carpelan-Holmstrom M., Nordling S., Pukkala E., et al. Does anyone survive pancreatic ductal adenocarcinoma?. A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54 (2005) 385-387
7. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 60 (1987) 2284-2303
8. Cameron J.L., Riall T.S., Coleman J., and Belcher K. One thousand consecutive pancreaticoduodenectomies. Ann Surg 144 (2006) 10-15
9. Richter A., Niedergethmann M., Sturm J.W., et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27 (2003) 324-329
10. Wagner M., Redaelli C., Lietz M., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91 (2004) 586-594
11. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-731
12. Fong Y., Gonen M., Rubin D., et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242 (2005) 540-544
13. Lim J.E., Chien M.W., and Earle C.C. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237 (2003) 74-85
14. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226 (1997) 248-257
15. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
16. Begg C.B., Cramer L.D., Hoskins W.J., and Brennan M.F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747-1751
17. van Heek N.T., Kuhlmann K.F., Scholten R.J., et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242 (2005) 781-788 discussion
18. Nagakawa T., Konishi I., Ueno K., et al. The results and problems of extensive radical surgery for carcinoma of the head of the pancreas. Jpn J Surg 21 (1991) 262-267
19. Hishinuma S., Ogata Y., Tomikawa M., et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10 (2006) 511-518
20. Brennan M.F., Moccia R.D., and Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 223 (1996) 506-511
21. Buchler M.W., Wagner M., Schmied B.M., et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138 (2003) 1310-1314
22. Fernandez-del C.C., Rattner D.W., and Warshaw A.L. Standards for pancreatic resection in the 1990s. Arch Surg 130 (1995) 295-299
23. Neoptolemos J.P., Russell R.C., Bramhall S., and Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1,026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 84 (1997) 1370-1376
24. Cameron J.L., Pitt H.A., Yeo C.J., et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217 (1993) 430-435
25. Trede M., Schwall G., and Saeger H.D. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211 (1990) 447-458
26. Howard J.M. Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality. Ann Surg 168 (1968) 629-640
27. Z'graggen K., Uhl W., Friess H., and Buchler M.W. How to do a safe pancreatic anastomosis. J Hepatobiliary Pancreat Surg 9 (2002) 733-737
28. van Berge Henegouwen M.I., De Wit L.T., van Gulik T.M., et al. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 185 (1997) 18-24
29. Muscari F., Suc B., Kirzin S., et al. Risk factors for mortality and intra-abdominal complications after pancreatoduodenectomy: multivariate analysis in 300 patients. Surgery 139 (2006) 591-598
30. Bartoli F.G., Arnone G.B., Ravera G., and Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 11 (1991) 1831-1848
31. Lin J.W., Cameron J.L., Yeo C.J., et al. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 8 (2004) 951-959
32. Bassi C., Falconi M., Molinari E., et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg 242 (2005) 767-771 discussion
33. Duffas J.P., Suc B., Msika S., et al. A controlled randomized multicenter trial of pancreatogastrostomy or pancreatojejunostomy after pancreatoduodenectomy. Am J Surg 189 (2005) 720-729
34. Yeo C.J., Cameron J.L., Maher M.M., et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222 (1995) 580-588
35. Buchler M., Friess H., Klempa I., et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163 (1992) 125-130
36. Connor S., Alexakis N., Garden O.J., et al. Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92 (2005) 1059-1067
37. Kazanjian K.K., Hines O.J., Eibl G., and Reber H.A. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg 140 (2005) 849-854
38. Lin P.W., and Lin Y.J. Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodenectomy. Br J Surg 86 (1999) 603-607
39. Lin P.W., Shan Y.S., Lin Y.J., and Hung C.J. Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52 (2005) 1601-1604
40. Seiler C.A., Wagner M., Sadowski C., et al. Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4 (2000) 443-452
41. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
42. Tran K.T., Smeenk H.G., van Eijck C.H., et al. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
43. Wenger F.A., Jacobi C.A., Haubold K., et al. [Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma. Preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy]. Chirurg 70 (1999) 1454-1459
44. Diener M.K., Knaebel H.P., Heukaufer C., et al. A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245 (2007) 187-200
45. Hartel M., Wente M.N., Hinz U., et al. Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 140 (2005) 1094-1099
46. Tani M., Terasawa H., Kawai M., et al. Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg 243 (2006) 316-320
47. Farnell M.B., Pearson R.K., Sarr M.G., et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138 (2005) 618-628
48. Nimura Y., Nagino M., Kato H., et al. Standard versus extended lymphadenectomy for pancreatic cancer: A multicenter, randomized controlled trial. Pancreatology 4 (2004) 274
49. Pedrazzoli S., DiCarlo V., Dionigi R., et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228 (1998) 508-517
50. Riall T.S., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 9 (2005) 1191-1204
51. Yeo C.J., Cameron J.L., Sohn T.A., et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229 (1999) 613-622
52. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236 (2002) 355-366
53. Capussotti L., Massucco P., Ribero D., et al. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138 (2003) 1316-1322
54. Fortner J.G. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg 199 (1984) 418-425
55. Shoup M., Conlon K.C., Klimstra D., and Brennan M.F. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?. J Gastrointest Surg 7 (2003) 946-952
56. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7 (2006) 309-315
57. Conlon K.C., Labow D., Leung D., et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 234 (2001) 487-493
58. Büchler M.W., and Friess H. Evidence forward, drainage on retreat. Ann Surg 244 (2006) 8-9
59. Kawai M., Tani M., Terasawa H., et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: Prospective study for consecutive 104 patients. Ann Surg 244 (2006) 1-7
60. Cuschieri A., Hall A.W., and Clark J. Value of laparoscopy in the diagnosis and management of pancreatic carcinoma. Gut 19 (1978) 672-677
61. Warshaw A.L., Tepper J.E., and Shipley W.U. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 151 (1986) 76-80
62. Friess H., Kleeff J., Silva J.C., et al. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. J Am Coll Surg 186 (1998) 675-682
63. Stefanidis D., Grove K.D., Schwesinger W.H., and Thomas Jr. C.R. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol 17 (2006) 189-199
64. Gagner M., and Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 8 (1994) 408-410
65. Gagner M., and Pomp A. Laparoscopic pancreatic resection: Is it worthwhile?. J Gastrointest Surg 1 (1997) 20-26
66. Kimura Y., Hirata K., Mukaiya M., et al. Hand-assisted laparoscopic pylorus-preserving pancreaticoduodenectomy for pancreas head disease. Am J Surg 189 (2005) 734-737
67. Mabrut J.Y., Fernandez-Cruz L., Azagra J.S., et al. Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 137 (2005) 597-605
68. Staudacher C., Orsenigo E., Baccari P., et al. Laparoscopic assisted duodenopancreatectomy. Surg Endosc 19 (2005) 352-356
69. Neuhaus P., Oettle H., Post S., et al. A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer. J Clin Oncol 23 (2005) 4013
70. Conlon K.C., Klimstra D.S., and Brennan M.F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 223 (1996) 273-279
71. Morrow M., Hilaris B., and Brennan M.F. Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980. Ann Surg 199 (1984) 1-5
72. Heslin M.J., Brooks A.D., Hochwald S.N., et al. A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg 133 (1998) 149-154
73. Allen P.J., Jaques D.P., D'Angelica M., et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg 7 (2003) 970-977
74. Conlon K.C., Dougherty E., Klimstra D.S., et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 223 (1996) 134-140
75. Brennan M.F., Kattan M.W., Klimstra D., and Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240 (2004) 293-298
76. Kattan M.W., Karpeh M.S., Mazumdar M., and Brennan M.F. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21 (2003) 3647-3650
77. Eilber F.C., Brennan M.F., Eilber F.R., et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 101 (2004) 2270-2275
78. Peeters K.C., Kattan M.W., Hartgrink H.H., et al. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer 103 (2005) 702-707